name,category,termsATPase family, AAA domain containing 1,INTERPRO[450003154$IPR003593:ATPase, AAA+ type, core, 450003482$IPR003959:ATPase, AAA-type, core, 450003483$IPR003960:ATPase, AAA-type, conserved site]
ATPase family, AAA domain containing 1,SMART[760000335$SM00382:AAA]
ATPase family, AAA domain containing 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000811$isopeptide bond, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001592$ubl conjugation]
ATPase family, AAA domain containing 1,UP_SEQ_FEATURE[850006779$chain:ATPase family AAA domain-containing protein 1, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
ATPase, Ca++ transporting, plasma membrane 1,INTERPRO[450001556$IPR001757:ATPase, P-type, K/Mg/Cd/Cu/Zn/Na/Ca/Na/H-transporter, 450003534$IPR004014:ATPase, P-type cation-transporter, N-terminal, 450005281$IPR005834:Haloacid dehalogenase-like hydrolase, 450005504$IPR006068:ATPase, P-type cation-transporter, C-terminal, 450005830$IPR006408:ATPase, P-type, calcium-transporting, PMCA-type, 450007545$IPR008250:ATPase, P-type, ATPase-associated region, 450016587$IPR018303:ATPase, P-type phosphorylation site]
ATPase, Ca++ transporting, plasma membrane 1,KEGG_PATHWAY[470038829$hsa04020:Calcium signaling pathway]
ATPase, Ca++ transporting, plasma membrane 1,PIR_SUPERFAMILY[630001445$PIRSF001297:Na(+)/K(+)-transporting ATPase alpha chain]
ATPase, Ca++ transporting, plasma membrane 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000134$ATP, 790000138$atp-binding, 790000211$calcium, 790000215$calcium transport, 790000218$calmodulin-binding, 790000264$cell membrane, 790000356$complete proteome, 790000743$hydrolase, 790000798$ion transport, 790000899$magnesium, 790000919$membrane, 790000937$metal-binding, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane, 790001556$transmembrane protein, 790001558$transport]
ATPase, Ca++ transporting, plasma membrane 1,UP_SEQ_FEATURE[850000003$active site:4-aspartylphosphate intermediate, 850039438$chain:Plasma membrane calcium-transporting ATPase 1, 850102572$compositionally biased region:Poly-Glu, 850106107$metal ion-binding site:Magnesium, 850106258$modified residue, 850111170$region of interest:Calmodulin-binding subdomain A, 850111171$region of interest:Calmodulin-binding subdomain B, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
ATPase, Ca++ transporting, type 2C, member 1,INTERPRO[450000595$IPR000695:ATPase, P-type, H+ transporting proton pump, 450001556$IPR001757:ATPase, P-type, K/Mg/Cd/Cu/Zn/Na/Ca/Na/H-transporter, 450003534$IPR004014:ATPase, P-type cation-transporter, N-terminal, 450005281$IPR005834:Haloacid dehalogenase-like hydrolase, 450005504$IPR006068:ATPase, P-type cation-transporter, C-terminal, 450005835$IPR006413:ATPase, P-type, calcium-transporting, PMR1-type, 450007545$IPR008250:ATPase, P-type, ATPase-associated region, 450016587$IPR018303:ATPase, P-type phosphorylation site]
ATPase, Ca++ transporting, type 2C, member 1,OMIM_DISEASE[520000549$benign chronic pemphigus (Hailey-Hailey disease), 520002207$Hailey-Hailey disease]
ATPase, Ca++ transporting, type 2C, member 1,PIR_SUPERFAMILY[630001445$PIRSF001297:Na(+)/K(+)-transporting ATPase alpha chain]
ATPase, Ca++ transporting, type 2C, member 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000211$calcium, 790000215$calcium transport, 790000356$complete proteome, 790000446$disease mutation, 790000624$golgi apparatus, 790000743$hydrolase, 790000798$ion transport, 790000899$magnesium, 790000919$membrane, 790000937$metal-binding, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane, 790001558$transport]
ATPase, Ca++ transporting, type 2C, member 1,UP_SEQ_FEATURE[850000003$active site:4-aspartylphosphate intermediate, 850009067$chain:Calcium-transporting ATPase type 2C member 1, 850105918$metal ion-binding site:Calcium 2, 850105922$metal ion-binding site:Calcium 2; via carbonyl oxygen, 850106107$metal ion-binding site:Magnesium, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
C-type lectin domain family 17, member A,INTERPRO[450001149$IPR001304:C-type lectin, 450014523$IPR016186:C-type lectin-like, 450016659$IPR018378:C-type lectin, conserved site]
C-type lectin domain family 17, member A,SMART[760000026$SM00034:CLECT]
C-type lectin domain family 17, member A,SP_PIR_KEYWORDS[790000356$complete proteome, 790000848$Lectin, 790000919$membrane, 790001555$transmembrane]
C-type lectin domain family 17, member A,UP_SEQ_FEATURE[850008692$chain:C-type lectin and transmembrane domain- containing protein FLJ45910, 850103184$domain:C-type lectin, 850118623$transmembrane region]
CUG triplet repeat, RNA binding protein 1,INTERPRO[450000430$IPR000504:RNA recognition motif, RNP-1, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait, 450014322$IPR015903:Ribonucleoprotein, BRUNO-like]
CUG triplet repeat, RNA binding protein 1,SMART[760000328$SM00360:RRM]
CUG triplet repeat, RNA binding protein 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000020$activator, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000988$mrna processing, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat, 790001339$rna-binding]
CUG triplet repeat, RNA binding protein 1,UP_SEQ_FEATURE[850012820$chain:CUG-BP- and ETR-3-like factor 1, 850102597$compositionally biased region:Ser-rich, 850105212$domain:RRM 1, 850105213$domain:RRM 2, 850105214$domain:RRM 3, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850118574$splice variant, 850118575$strand, 850118624$turn]
DIS3 mitotic control homolog (S. cerevisiae)-like,INTERPRO[450001682$IPR001900:Ribonuclease II and R]
DIS3 mitotic control homolog (S. cerevisiae)-like,PIR_SUPERFAMILY[630006771$PIRSF006825:mitotic control protein Dis3]
DIS3 mitotic control homolog (S. cerevisiae)-like,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000523$exonuclease, 790000743$hydrolase, 790001049$nuclease, 790001212$polymorphism, 790001339$rna-binding]
DIS3 mitotic control homolog (S. cerevisiae)-like,UP_SEQ_FEATURE[850015252$chain:DIS3-like exonuclease 1, 850117295$sequence variant, 850118574$splice variant]
DPH2 homolog (S. cerevisiae),INTERPRO[450002419$IPR002728:Diphthamide synthesis, DPH1/DHP2, 450009098$IPR010014:Diphthamide synthesis, DHP2]
DPH2 homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein]
DPH2 homolog (S. cerevisiae),UP_SEQ_FEATURE[850015237$chain:Diphthamide biosynthesis protein 2, 850106258$modified residue, 850117294$sequence conflict]
EGF, latrophilin and seven transmembrane domain containing 1,INTERPRO[450000128$IPR000152:EGF-type aspartate/asparagine hydroxylation conserved site, 450000174$IPR000203:GPS, 450000637$IPR000742:EGF-like, type 3, 450000724$IPR000832:GPCR, family 2, secretin-like, 450001663$IPR001881:EGF-like calcium-binding, 450005636$IPR006210:EGF-like, 450011699$IPR013032:EGF-like region, conserved site, 450011735$IPR013091:EGF calcium-binding, 450016289$IPR017981:GPCR, family 2-like, 450016291$IPR017983:GPCR, family 2, secretin-like, conserved site, 450016397$IPR018097:EGF-like calcium-binding, conserved site, 450016532$IPR018247:EF-HAND 1]
EGF, latrophilin and seven transmembrane domain containing 1,SMART[760000153$SM00179:EGF_CA, 760000155$SM00181:EGF, 760000273$SM00303:GPS]
EGF, latrophilin and seven transmembrane domain containing 1,SP_PIR_KEYWORDS[790000211$calcium, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000481$egf-like domain, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001546$transducer, 790001555$transmembrane]
EGF, latrophilin and seven transmembrane domain containing 1,UP_SEQ_FEATURE[850016985$chain:EGF, latrophilin and seven transmembrane domain-containing protein 1, 850102572$compositionally biased region:Poly-Glu, 850102883$disulfide bond, 850103597$domain:EGF-like 1, 850103644$domain:EGF-like 2; calcium-binding, 850104076$domain:GPS, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850117969$site:Cleavage, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
FK506 binding protein 4, 59kDa,INTERPRO[450001034$IPR001179:Peptidyl-prolyl cis-trans isomerase, FKBP-type, 450001282$IPR001440:Tetratricopeptide TPR-1, 450010815$IPR011990:Tetratricopeptide-like helical, 450011693$IPR013026:Tetratricopeptide region, 450017972$IPR019734:Tetratricopeptide repeat]
FK506 binding protein 4, 59kDa,SMART[760000020$SM00028:TPR]
FK506 binding protein 4, 59kDa,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000394$cyclosporin A binding, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000810$Isomerase, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001343$Rotamase, 790001537$tpr repeat]
FK506 binding protein 4, 59kDa,UP_SEQ_FEATURE[850019530$chain:FK506-binding protein 4, 850019531$chain:FK506-binding protein 4, N-terminally processed, 850105059$domain:PPIase FKBP-type 1, 850105060$domain:PPIase FKBP-type 2, 850105852$helix, 850106258$modified residue, 850117119$repeat:TPR 1, 850117131$repeat:TPR 2, 850117141$repeat:TPR 3, 850117295$sequence variant, 850118575$strand, 850118624$turn]
Fas apoptotic inhibitory molecule 3,INTERPRO[450003160$IPR003599:Immunoglobulin subtype, 450011788$IPR013151:Immunoglobulin, 450012396$IPR013783:Immunoglobulin-like fold]
Fas apoptotic inhibitory molecule 3,SMART[760000357$SM00409:IG]
Fas apoptotic inhibitory molecule 3,SP_PIR_KEYWORDS[790000356$complete proteome, 790000447$disulfide bond, 790000763$immune response, 790000768$Immunoglobulin domain, 790000919$membrane, 790001405$signal, 790001555$transmembrane]
Fas apoptotic inhibitory molecule 3,UP_SEQ_FEATURE[850018982$chain:Fas apoptotic inhibitory molecule 3, 850102404$compositionally biased region:Arg-rich, 850102883$disulfide bond, 850104199$domain:Ig-like, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
H3 histone, family 3B (H3.3B); H3 histone, family 3A pseudogene; H3 histone, family 3A; similar to H3 histone, family 3B; similar to histone H3.3B,INTERPRO[450000140$IPR000164:Histone H3, 450006498$IPR007125:Histone core, 450008207$IPR009072:Histone-fold]
H3 histone, family 3B (H3.3B); H3 histone, family 3A pseudogene; H3 histone, family 3A; similar to H3 histone, family 3B; similar to histone H3.3B,KEGG_PATHWAY[470038916$hsa05322:Systemic lupus erythematosus]
H3 histone, family 3B (H3.3B); H3 histone, family 3A pseudogene; H3 histone, family 3A; similar to H3 histone, family 3B; similar to histone H3.3B,PIR_SUPERFAMILY[630002185$PIRSF002051:histone H3]
H3 histone, family 3B (H3.3B); H3 histone, family 3A pseudogene; H3 histone, family 3A; similar to H3 histone, family 3B; similar to histone H3.3B,SMART[760000374$SM00428:H3]
H3 histone, family 3B (H3.3B); H3 histone, family 3A pseudogene; H3 histone, family 3A; similar to H3 histone, family 3B; similar to histone H3.3B,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000015$acetyllysine, 790000315$chromosomal protein, 790000326$citrullination, 790000356$complete proteome, 790000445$direct protein sequencing, 790000449$DNA binding, 790000466$dna-binding, 790000950$methylated amino acid, 790000953$methylation, 790001058$nucleosome core, 790001065$nucleus, 790001162$phosphoprotein, 790001592$ubl conjugation]
H3 histone, family 3B (H3.3B); H3 histone, family 3A pseudogene; H3 histone, family 3A; similar to H3 histone, family 3B; similar to histone H3.3B,UP_SEQ_FEATURE[850024091$chain:Histone H3.3, 850106258$modified residue, 850117294$sequence conflict]
Ly6/neurotoxin 1,INTERPRO[450001358$IPR001526:CD59 antigen, 450014439$IPR016054:Ly-6 antigen / uPA receptor -like, 450016648$IPR018363:CD59 antigen, conserved site]
Ly6/neurotoxin 1,PIR_SUPERFAMILY[630002157$PIRSF002021:Ly-6-like protein]
Ly6/neurotoxin 1,SMART[760000116$SM00134:LU]
Ly6/neurotoxin 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000628$gpi-anchor, 790000881$lipoprotein, 790000919$membrane, 790001363$Secreted, 790001405$signal]
Ly6/neurotoxin 1,UP_SEQ_FEATURE[850029207$chain:Ly-6/neurotoxin-like protein 1, 850059126$chain:Secreted Ly-6/uPAR-related protein 2, 850102883$disulfide bond, 850105609$domain:UPAR/Ly6, 850105852$helix, 850105860$lipid moiety-binding region:GPI-anchor amidated glycine, 850109701$propeptide:Removed in mature form, 850117814$signal peptide, 850118575$strand, 850118624$turn]
NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa,INTERPRO[450008527$IPR009423:NADH:ubiquinone oxidoreductase, subunit b14.5b]
NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa,KEGG_PATHWAY[470038741$hsa00190:Oxidative phosphorylation, 470038891$hsa05010:Alzheimer's disease, 470038892$hsa05012:Parkinson's disease, 470038894$hsa05016:Huntington's disease]
NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa,PIR_SUPERFAMILY[630014491$PIRSF017834:NADH dehydrogenase [ubiquinone] (complex I), subunit C2, 630014492$PIRSF017834:NADH-UbQ_OxRdtase_b14.5b]
NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000489$electron transport, 790000919$membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001006$nad, 790001092$oxidoreductase, 790001212$polymorphism, 790001309$respiratory chain, 790001555$transmembrane, 790001558$transport]
NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa,UP_SEQ_FEATURE[850033542$chain:NADH dehydrogenase [ubiquinone] 1 subunit C2, 850106258$modified residue, 850117295$sequence variant, 850118623$transmembrane region]
NADPH oxidase activator 1,INTERPRO[450000090$IPR000108:Neutrophil cytosol factor 2, 450000235$IPR000270:Octicosapeptide/Phox/Bem1p, 450001282$IPR001440:Tetratricopeptide TPR-1, 450001294$IPR001452:Src homology-3 domain, 450010815$IPR011990:Tetratricopeptide-like helical, 450011693$IPR013026:Tetratricopeptide region, 450017972$IPR019734:Tetratricopeptide repeat]
NADPH oxidase activator 1,SMART[760000020$SM00028:TPR, 760000295$SM00326:SH3, 760000579$SM00666:PB1]
NADPH oxidase activator 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001398$sh3 domain, 790001537$tpr repeat]
NADPH oxidase activator 1,UP_SEQ_FEATURE[850033705$chain:NADPH oxidase activator 1, 850104868$domain:OPR, 850105350$domain:SH3, 850106258$modified residue, 850106259$mutagenesis site, 850113380$region of interest:Mediates interaction with RAC1, 850117119$repeat:TPR 1, 850117131$repeat:TPR 2, 850117141$repeat:TPR 3, 850117142$repeat:TPR 4, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
PDZ domain containing 7,INTERPRO[450001316$IPR001478:PDZ/DHR/GLGF]
PDZ domain containing 7,SMART[760000200$SM00228:PDZ]
PDZ domain containing 7,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790001304$repeat]
PDZ domain containing 7,UP_SEQ_FEATURE[850036987$chain:PDZ domain-containing protein 7, 850102597$compositionally biased region:Ser-rich, 850104919$domain:PDZ 1, 850104924$domain:PDZ 2, 850105852$helix, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand]
RAB42, member RAS oncogene family,INTERPRO[450001599$IPR001806:Ras GTPase, 450012373$IPR013753:Ras]
RAB42, member RAS oncogene family,SP_PIR_KEYWORDS[790000356$complete proteome, 790000639$gtp-binding, 790000881$lipoprotein, 790000919$membrane, 790000953$methylation, 790001063$nucleotide-binding, 790001236$prenylation]
RAB42, member RAS oncogene family,UP_SEQ_FEATURE[850054008$chain:Putative Ras-related protein Rab-42, 850105894$lipid moiety-binding region:S-geranylgeranyl cysteine, 850106258$modified residue, 850106296$nucleotide phosphate-binding region:GTP]
SEC24 family, member C (S. cerevisiae),COG_ONTOLOGY[90000079$Intracellular trafficking and secretion]
SEC24 family, member C (S. cerevisiae),INTERPRO[450006295$IPR006895:Zinc finger, Sec23/Sec24-type, 450006296$IPR006896:Sec23/Sec24 trunk region, 450006300$IPR006900:Sec23/Sec24 helical region, 450006497$IPR007123:Gelsolin region, 450011666$IPR012990:Sec23/Sec24 beta-sandwich]
SEC24 family, member C (S. cerevisiae),PIR_SUPERFAMILY[630013991$PIRSF017225:vesicle coat complex COPII, subunit SEC24]
SEC24 family, member C (S. cerevisiae),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000499$endoplasmic reticulum, 790000510$er-golgi transport, 790000624$golgi apparatus, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001266$protein transport, 790001558$transport]
SEC24 family, member C (S. cerevisiae),UP_SEQ_FEATURE[850048117$chain:Protein transport protein Sec24C, 850105852$helix, 850106258$modified residue, 850115067$region of interest:Zinc finger-like, 850117295$sequence variant, 850118575$strand, 850118624$turn]
SWAP switching B-cell complex 70kDa subunit,INTERPRO[450001635$IPR001849:Pleckstrin homology, 450010818$IPR011993:Pleckstrin homology-type]
SWAP switching B-cell complex 70kDa subunit,SMART[760000205$SM00233:PH]
SWAP switching B-cell complex 70kDa subunit,SP_PIR_KEYWORDS[790000002$3d-structure, 790000264$cell membrane, 790000267$cell projection, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000466$dna-binding, 790000919$membrane, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
SWAP switching B-cell complex 70kDa subunit,UP_SEQ_FEATURE[850063139$chain:Switch-associated protein 70, 850102577$compositionally biased region:Poly-Lys, 850104979$domain:PH, 850105852$helix, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand]
StAR-related lipid transfer (START) domain containing 6,INTERPRO[450002572$IPR002913:Lipid-binding START]
StAR-related lipid transfer (START) domain containing 6,SMART[760000206$SM00234:START]
StAR-related lipid transfer (START) domain containing 6,SP_PIR_KEYWORDS[790000356$complete proteome, 790000875$lipid transport, 790000876$lipid-binding, 790001212$polymorphism, 790001558$transport]
StAR-related lipid transfer (START) domain containing 6,UP_SEQ_FEATURE[850062384$chain:StAR-related lipid transfer protein 6, 850105403$domain:START, 850117295$sequence variant]
WAP four-disulfide core domain 2,INTERPRO[450007512$IPR008197:Whey acidic protein, 4-disulphide core, 450014297$IPR015874:4-disulphide core, 450016370$IPR018069:Whey acidic protein, 4-disulphide core, conserved site]
WAP four-disulfide core domain 2,SMART[760000190$SM00217:WAP]
WAP four-disulfide core domain 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790001253$protease inhibitor, 790001304$repeat, 790001363$Secreted, 790001385$Serine protease inhibitor, 790001405$signal]
WAP four-disulfide core domain 2,UP_SEQ_FEATURE[850100661$chain:WAP four-disulfide core domain protein 2, 850102883$disulfide bond, 850105689$domain:WAP 1, 850105691$domain:WAP 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117814$signal peptide, 850118574$splice variant]
YME1-like 1 (S. cerevisiae),INTERPRO[450000549$IPR000642:Peptidase M41, 450003154$IPR003593:ATPase, AAA+ type, core, 450003482$IPR003959:ATPase, AAA-type, core, 450003483$IPR003960:ATPase, AAA-type, conserved site, 450005380$IPR005936:Peptidase M41, FtsH]
YME1-like 1 (S. cerevisiae),SMART[760000335$SM00382:AAA]
YME1-like 1 (S. cerevisiae),SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000743$hydrolase, 790000937$metal-binding, 790000941$metalloprotease, 790000969$mitochondrion, 790001063$nucleotide-binding, 790001252$Protease, 790001648$zinc]
YME1-like 1 (S. cerevisiae),UP_SEQ_FEATURE[850006648$chain:ATP-dependent metalloprotease YME1L1, 850106244$metal ion-binding site:Zinc; catalytic, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850118574$splice variant]
acylphosphatase 1, erythrocyte (common) type,INTERPRO[450001585$IPR001792:Acylphosphatase, 450001586$IPR001792:Acylphosphatase-like, 450016276$IPR017968:Acylphosphatase, conserved site]
acylphosphatase 1, erythrocyte (common) type,KEGG_PATHWAY[470038787$hsa00620:Pyruvate metabolism]
acylphosphatase 1, erythrocyte (common) type,PIR_SUPERFAMILY[630001412$PIRSF001266:acylphosphatase]
acylphosphatase 1, erythrocyte (common) type,SP_PIR_KEYWORDS[790000002$3d-structure, 790000011$acetylated amino end, 790000012$acetylation, 790000356$complete proteome, 790000411$cytosol, 790000445$direct protein sequencing, 790000512$erythrocyte, 790000743$hydrolase]
acylphosphatase 1, erythrocyte (common) type,UP_SEQ_FEATURE[850003803$chain:Acylphosphatase-1, 850103019$domain:Acylphosphatase-like, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850118575$strand]
adducin 3 (gamma),INTERPRO[450001148$IPR001303:Class II aldolase/adducin, N-terminal]
adducin 3 (gamma),SP_PIR_KEYWORDS[790000019$actin-binding, 790000053$alternative splicing, 790000195$blood pressure control, 790000218$calmodulin-binding, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000679$heterodimer, 790000919$membrane, 790001162$phosphoprotein, 790001483$tail protein, 790001592$ubl conjugation]
adducin 3 (gamma),UP_SEQ_FEATURE[850020475$chain:Gamma-adducin, 850106258$modified residue, 850112141$region of interest:Interaction with calmodulin, 850117294$sequence conflict, 850118574$splice variant]
adenylate kinase 2,INTERPRO[450000742$IPR000850:Adenylate kinase, 450005685$IPR006259:Adenylate kinase, subfamily, 450007210$IPR007862:Adenylate kinase, zinc-finger lid region]
adenylate kinase 2,KEGG_PATHWAY[470038742$hsa00230:Purine metabolism]
adenylate kinase 2,PIR_SUPERFAMILY[630000849$PIRSF000734:adenylate kinase]
adenylate kinase 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000134$ATP, 790000138$atp-binding, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000447$disulfide bond, 790000825$kinase, 790000969$mitochondrion, 790001063$nucleotide-binding, 790001097$P-loop, 790001168$phosphotransferase, 790001212$polymorphism, 790001547$transferase]
adenylate kinase 2,UP_SEQ_FEATURE[850000229$binding site:AMP, 850003913$chain:Adenylate kinase 2, mitochondrial, 850102883$disulfide bond, 850105852$helix, 850106258$modified residue, 850106262$nucleotide phosphate-binding region:AMP, 850106263$nucleotide phosphate-binding region:ATP, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
apolipoprotein M,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790000643$hdl, 790000875$lipid transport, 790000881$lipoprotein, 790001363$Secreted, 790001405$signal, 790001558$transport]
apolipoprotein M,UP_SEQ_FEATURE[850005829$chain:Apolipoprotein M, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106259$mutagenesis site, 850117294$sequence conflict, 850117814$signal peptide, 850118575$strand]
aurora kinase B,INTERPRO[450000618$IPR000719:Protein kinase, core, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
aurora kinase B,SMART[760000193$SM00220:S_TKc]
aurora kinase B,SP_PIR_KEYWORDS[790000012$acetylation, 790000138$atp-binding, 790000258$cell cycle, 790000260$cell division, 790000276$centromere, 790000315$chromosomal protein, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000825$kinase, 790000899$magnesium, 790000937$metal-binding, 790000973$mitosis, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase]
aurora kinase B,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850059727$chain:Serine/threonine-protein kinase 12, 850105086$domain:Protein kinase, 850106258$modified residue, 850106259$mutagenesis site, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant]
calcium/calmodulin-dependent protein kinase II gamma,BIOCARTA[30000039$h_biopeptidesPathway:Bioactive Peptide Induced Signaling Pathway, 30000043$h_CaCaMPathway:Ca++/ Calmodulin-dependent Protein Kinase Activation, 30000070$h_crebPathway:Transcription factor CREB and its extracellular signals, 30000226$h_pgc1aPathway:Regulation of PGC-1a, 30000279$h_stathminPathway:Stathmin and breast cancer resistance to antimicrotubule agents]
calcium/calmodulin-dependent protein kinase II gamma,INTERPRO[450000618$IPR000719:Protein kinase, core, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450012167$IPR013543:Calcium/calmodulin dependent protein kinase II, association-domain, 450014177$IPR015742:Calcium/calmodulin-dependent protein kinase II isoform, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
calcium/calmodulin-dependent protein kinase II gamma,KEGG_PATHWAY[470038828$hsa04012:ErbB signaling pathway, 470038829$hsa04020:Calcium signaling pathway, 470038835$hsa04114:Oocyte meiosis, 470038846$hsa04310:Wnt signaling pathway, 470038876$hsa04720:Long-term potentiation, 470038877$hsa04722:Neurotrophin signaling pathway, 470038879$hsa04740:Olfactory transduction, 470038883$hsa04912:GnRH signaling pathway, 470038885$hsa04916:Melanogenesis, 470038904$hsa05214:Glioma]
calcium/calmodulin-dependent protein kinase II gamma,PIR_SUPERFAMILY[630000701$PIRSF000594:calcium/calmodulin-dependent protein kinase II]
calcium/calmodulin-dependent protein kinase II gamma,SMART[760000193$SM00220:S_TKc]
calcium/calmodulin-dependent protein kinase II gamma,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000138$atp-binding, 790000218$calmodulin-binding, 790000356$complete proteome, 790000825$kinase, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase]
calcium/calmodulin-dependent protein kinase II gamma,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850009093$chain:Calcium/calmodulin-dependent protein kinase type II subunit gamma, 850105086$domain:Protein kinase, 850105852$helix, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850111164$region of interest:Calmodulin-binding, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
cardiotrophin-like cytokine factor 1,INTERPRO[450009726$IPR010681:Plethodontid receptivity factor PRF]
cardiotrophin-like cytokine factor 1,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038866$hsa04630:Jak-STAT signaling pathway]
cardiotrophin-like cytokine factor 1,OMIM_DISEASE[520001076$Cold-induced sweating syndrome 1]
cardiotrophin-like cytokine factor 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000402$cytokine, 790000446$disease mutation, 790000616$glycoprotein, 790001363$Secreted, 790001405$signal]
cardiotrophin-like cytokine factor 1,UP_SEQ_FEATURE[850009721$chain:Cardiotrophin-like cytokine factor 1, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide]
chromosome 1 open reading frame 122,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome]
chromosome 1 open reading frame 122,UP_SEQ_FEATURE[850073586$chain:Uncharacterized protein C1orf122]
chromosome 14 open reading frame 129,INTERPRO[450007310$IPR007967:Protein of unknown function DUF727]
chromosome 14 open reading frame 129,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000407$cytoplasm]
chromosome 14 open reading frame 129,UP_SEQ_FEATURE[850022508$chain:GSK3-beta interaction protein, 850105852$helix, 850106259$mutagenesis site, 850112379$region of interest:Interaction with GSK3B, 850117294$sequence conflict, 850118575$strand]
chromosome 15 open reading frame 27,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
chromosome 15 open reading frame 27,UP_SEQ_FEATURE[850066259$chain:Transmembrane protein C15orf27, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
chromosome 17 open reading frame 45,SP_PIR_KEYWORDS[790000356$complete proteome, 790000969$mitochondrion, 790001212$polymorphism, 790001550$transit peptide]
chromosome 17 open reading frame 45,UP_SEQ_FEATURE[850055486$chain:Putative uncharacterized protein NCRNA00188, mitochondrial, 850117295$sequence variant, 850118617$transit peptide:Mitochondrion]
chromosome 19 open reading frame 62,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000311$chromatin regulator, 790000356$complete proteome, 790000407$cytoplasm, 790000452$DNA damage, 790000459$dna repair, 790001065$nucleus, 790001162$phosphoprotein]
chromosome 19 open reading frame 62,UP_SEQ_FEATURE[850008345$chain:BRCA1-A complex subunit MERIT40, 850106258$modified residue, 850115054$region of interest:VWFA-like, 850117294$sequence conflict, 850118574$splice variant]
citron (rho-interacting, serine/threonine kinase 21),COG_ONTOLOGY[90000025$Cell division and chromosome partitioning]
citron (rho-interacting, serine/threonine kinase 21),INTERPRO[450000618$IPR000719:Protein kinase, core, 450000836$IPR000961:AGC-kinase, C-terminal, 450001035$IPR001180:Citron-like, 450001635$IPR001849:Pleckstrin homology, 450001967$IPR002219:Protein kinase C, phorbol ester/diacylglycerol binding, 450001968$IPR002219:Protein kinase C-like, phorbol ester/diacylglycerol binding, 450002035$IPR002290:Serine/threonine protein kinase, 450004935$IPR005479:Carbamoyl phosphate synthetase, large subunit, ATP-binding, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450010818$IPR011993:Pleckstrin homology-type, 450015732$IPR017405:Citron Rho-interacting kinase, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related, 450016207$IPR017892:Protein kinase, C-terminal]
citron (rho-interacting, serine/threonine kinase 21),PIR_SUPERFAMILY[630029748$PIRSF038145:citron Rho-interacting kinase, 630029749$PIRSF038145:Citron_Rho-interacting_kinase]
citron (rho-interacting, serine/threonine kinase 21),SMART[760000028$SM00036:CNH, 760000096$SM00109:C1, 760000115$SM00133:S_TK_X, 760000193$SM00220:S_TKc, 760000205$SM00233:PH]
citron (rho-interacting, serine/threonine kinase 21),SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000138$atp-binding, 790000258$cell cycle, 790000260$cell division, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000428$developmental protein, 790000434$differentiation, 790000825$kinase, 790000937$metal-binding, 790000973$mitosis, 790001016$neurogenesis, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001399$sh3-binding, 790001547$transferase, 790001648$zinc, 790001651$zinc-finger]
citron (rho-interacting, serine/threonine kinase 21),UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850011548$chain:Citron Rho-interacting kinase, 850103028$domain:AGC-kinase C-terminal, 850103376$domain:CNH, 850104979$domain:PH, 850105086$domain:Protein kinase, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850112777$region of interest:Interaction with Rho/Rac, 850117294$sequence conflict, 850117295$sequence variant, 850117711$short sequence motif:SH3-binding, 850118574$splice variant, 850118892$zinc finger region:Phorbol-ester/DAG-type]
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage),INTERPRO[450003099$IPR003532:Short hematopoietin receptor, family 2, conserved site, 450003484$IPR003961:Fibronectin, type III, 450008173$IPR008957:Fibronectin, type III-like fold]
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage),KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038866$hsa04630:Jak-STAT signaling pathway, 470038867$hsa04640:Hematopoietic cell lineage, 470038899$hsa05200:Pathways in cancer]
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage),OMIM_DISEASE[520001195$Converging evidence for a pseudoautosomal cytokine receptor gene locus in schizophrenia, 520002838$Leukemia, acute myeloid, M2 type, 520004183$Pulmonary alveolar proteinosis]
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage),SMART[760000051$SM00060:FN3]
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000446$disease mutation, 790000447$disulfide bond, 790000616$glycoprotein, 790000634$growth factor receptor, 790000919$membrane, 790001301$receptor, 790001363$Secreted, 790001405$signal, 790001555$transmembrane, 790001556$transmembrane protein]
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage),UP_SEQ_FEATURE[850022370$chain:Granulocyte-macrophage colony-stimulating factor receptor subunit alpha, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117329$short sequence motif:Box 1 motif, 850117767$short sequence motif:WSXWS motif, 850117814$signal peptide, 850118574$splice variant, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
cortistatin; apoptosis-inducing, TAF9-like domain 1,INTERPRO[450016435$IPR018142:Somatostatin/Cortistatin, C-terminal]
cortistatin; apoptosis-inducing, TAF9-like domain 1,PIR_SUPERFAMILY[630001951$PIRSF001814:somatostatin]
cortistatin; apoptosis-inducing, TAF9-like domain 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000276$centromere, 790000315$chromosomal protein, 790000329$cleavage on pair of basic residues, 790000356$complete proteome, 790000447$disulfide bond, 790000708$hormone, 790001065$nucleus, 790001363$Secreted, 790001405$signal]
cortistatin; apoptosis-inducing, TAF9-like domain 1,UP_SEQ_FEATURE[850010673$chain:Centromere protein S, 850102883$disulfide bond, 850107247$peptide:Cortistatin-17, 850107248$peptide:Cortistatin-29, 850117814$signal peptide, 850118574$splice variant]
cytochrome P450, family 27, subfamily B, polypeptide 1,BIOCARTA[30000211$h_nuclearRsPathway:Nuclear Receptors in Lipid Metabolism and Toxicity]
cytochrome P450, family 27, subfamily B, polypeptide 1,COG_ONTOLOGY[90000104$Secondary metabolites biosynthesis, transport, and catabolism]
cytochrome P450, family 27, subfamily B, polypeptide 1,INTERPRO[450000989$IPR001128:Cytochrome P450, 450002134$IPR002401:Cytochrome P450, E-class, group I, 450016280$IPR017972:Cytochrome P450, conserved site, 450016281$IPR017973:Cytochrome P450, C-terminal region]
cytochrome P450, family 27, subfamily B, polypeptide 1,KEGG_PATHWAY[470038736$hsa00100:Steroid biosynthesis]
cytochrome P450, family 27, subfamily B, polypeptide 1,OMIM_DISEASE[520005036$vitamin D-dependent rickets type I, 520005037$Vitamin D-dependent rickets, type I]
cytochrome P450, family 27, subfamily B, polypeptide 1,PIR_SUPERFAMILY[630000059$PIRSF000046:cytochrome P450 CYP11B1]
cytochrome P450, family 27, subfamily B, polypeptide 1,SP_PIR_KEYWORDS[790000314$chromoprotein, 790000356$complete proteome, 790000446$disease mutation, 790000652$heme, 790000802$iron, 790000919$membrane, 790000937$metal-binding, 790000943$metalloprotein, 790000969$mitochondrion, 790000984$Monooxygenase, 790001008$nadp, 790001092$oxidoreductase, 790001212$polymorphism, 790001550$transit peptide]
cytochrome P450, family 27, subfamily B, polypeptide 1,UP_SEQ_FEATURE[850001225$chain:25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial, 850106026$metal ion-binding site:Iron (heme axial ligand), 850117295$sequence variant, 850118617$transit peptide:Mitochondrion]
discs, large (Drosophila) homolog-associated protein 3,INTERPRO[450004495$IPR005026:Guanylate-kinase-associated protein]
discs, large (Drosophila) homolog-associated protein 3,PIR_SUPERFAMILY[630014622$PIRSF017965:disks large-associated protein 1]
discs, large (Drosophila) homolog-associated protein 3,SP_PIR_KEYWORDS[790000263$cell junction, 790000264$cell membrane, 790000356$complete proteome, 790000919$membrane, 790001162$phosphoprotein, 790001223$postsynaptic cell membrane, 790001475$synapse]
discs, large (Drosophila) homolog-associated protein 3,UP_SEQ_FEATURE[850015435$chain:Disks large-associated protein 3, 850102574$compositionally biased region:Poly-His, 850106258$modified residue]
ectodermal-neural cortex (with BTB-like domain),INTERPRO[450000181$IPR000210:BTB/POZ-like, 450006067$IPR006652:Kelch repeat type 1, 450010229$IPR011333:BTB/POZ fold, 450010533$IPR011705:BTB/Kelch-associated, 450011722$IPR013069:BTB/POZ, 450011733$IPR013089:Kelch related, 450014332$IPR015915:Kelch-type beta propeller, 450014333$IPR015916:Galactose oxidase, beta-propeller, 450015416$IPR017096:Kelch-like protein, gigaxonin]
ectodermal-neural cortex (with BTB-like domain),PIR_SUPERFAMILY[630028539$PIRSF037037:Kelch-like_protein_gigaxonin]
ectodermal-neural cortex (with BTB-like domain),SMART[760000197$SM00225:BTB, 760000541$SM00612:Kelch]
ectodermal-neural cortex (with BTB-like domain),SP_PIR_KEYWORDS[790000019$actin-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000428$developmental protein, 790000819$kelch repeat, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001592$ubl conjugation, 790001593$ubl conjugation pathway]
ectodermal-neural cortex (with BTB-like domain),UP_SEQ_FEATURE[850016911$chain:Ectoderm-neural cortex protein 1, 850103177$domain:BTB, 850106258$modified residue, 850116239$repeat:Kelch 1, 850116250$repeat:Kelch 2, 850116251$repeat:Kelch 3, 850116252$repeat:Kelch 4, 850116253$repeat:Kelch 5, 850116254$repeat:Kelch 6, 850117294$sequence conflict, 850117295$sequence variant]
erythroid associated factor,BIOCARTA[30000009$h_ahspPathway:Hemoglobin's Chaperone, 30000018$h_amiPathway:Acute Myocardial Infarction]
erythroid associated factor,INTERPRO[450013759$IPR015317:Alpha-haemoglobin stabilising protein]
erythroid associated factor,SP_PIR_KEYWORDS[790000002$3d-structure, 790000288$Chaperone, 790000356$complete proteome, 790000407$cytoplasm, 790001212$polymorphism]
erythroid associated factor,UP_SEQ_FEATURE[850004799$chain:Alpha-hemoglobin-stabilizing protein, 850105852$helix, 850117294$sequence conflict, 850117295$sequence variant, 850118624$turn]
essential meiotic endonuclease 1 homolog 1 (S. pombe),INTERPRO[450005598$IPR006166:DNA repair nuclease, XPF-type/Helicase]
essential meiotic endonuclease 1 homolog 1 (S. pombe),KEGG_PATHWAY[470038825$hsa03440:Homologous recombination]
essential meiotic endonuclease 1 homolog 1 (S. pombe),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000452$DNA damage, 790000458$dna recombination, 790000459$dna repair, 790000498$Endonuclease, 790000743$hydrolase, 790000899$magnesium, 790000937$metal-binding, 790001049$nuclease, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
essential meiotic endonuclease 1 homolog 1 (S. pombe),UP_SEQ_FEATURE[850012709$chain:Crossover junction endonuclease EME1, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
etoposide induced 2.4 mRNA,INTERPRO[450008976$IPR009890:Etoposide-induced 2.4]
etoposide induced 2.4 mRNA,KEGG_PATHWAY[470038836$hsa04115:p53 signaling pathway]
etoposide induced 2.4 mRNA,PIR_SUPERFAMILY[630029664$PIRSF038080:etoposide-induced protein 2.4]
etoposide induced 2.4 mRNA,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001162$phosphoprotein, 790001555$transmembrane]
etoposide induced 2.4 mRNA,UP_SEQ_FEATURE[850018033$chain:Etoposide-induced protein 2.4 homolog, 850102566$compositionally biased region:Poly-Arg, 850106258$modified residue, 850117294$sequence conflict, 850118623$transmembrane region]
exosome component 10,INTERPRO[450001879$IPR002121:Helicase and RNase D C-terminal, HRDC, 450002278$IPR002562:3'-5' exonuclease, 450011268$IPR012588:Exosome-associated factor Rrp6, N-terminal]
exosome component 10,KEGG_PATHWAY[470038814$hsa03018:RNA degradation]
exosome component 10,SMART[760000309$SM00341:HRDC, 760000419$SM00474:35EXOc]
exosome component 10,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000523$exonuclease, 790000526$exosome, 790000743$hydrolase, 790001043$nonsense-mediated mrna decay, 790001049$nuclease, 790001065$nucleus, 790001339$rna-binding, 790001345$rrna processing]
exosome component 10,UP_SEQ_FEATURE[850018285$chain:Exosome component 10, 850104151$domain:HRDC, 850105852$helix, 850118574$splice variant, 850118575$strand, 850118624$turn]
family with sequence similarity 186, member B,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism]
family with sequence similarity 186, member B,UP_SEQ_FEATURE[850045923$chain:Protein FAM186B, 850117295$sequence variant]
glutathione S-transferase mu 1,INTERPRO[450002707$IPR003081:Glutathione S-transferase, Mu class, 450003562$IPR004045:Glutathione S-transferase, N-terminal, 450003563$IPR004046:Glutathione S-transferase, C-terminal, 450009996$IPR010987:Glutathione S-transferase, C-terminal-like, 450011036$IPR012335:Thioredoxin fold, 450016246$IPR017933:Glutathione S-transferase/chloride channel, C-terminal]
glutathione S-transferase mu 1,KEGG_PATHWAY[470038764$hsa00480:Glutathione metabolism, 470038808$hsa00980:Metabolism of xenobiotics by cytochrome P450, 470038809$hsa00982:Drug metabolism]
glutathione S-transferase mu 1,PIR_SUPERFAMILY[630000598$PIRSF000503:glutathione transferase]
glutathione S-transferase mu 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000436$dimer, 790000445$direct protein sequencing, 790001162$phosphoprotein, 790001212$polymorphism, 790001547$transferase]
glutathione S-transferase mu 1,UP_SEQ_FEATURE[850021800$chain:Glutathione S-transferase Mu 1, 850104084$domain:GST C-terminal, 850104087$domain:GST N-terminal, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
heparan sulfate proteoglycan 2,INTERPRO[450000027$IPR000034:Laminin B type IV, 450000068$IPR000082:SEA, 450000637$IPR000742:EGF-like, type 3, 450001280$IPR001438:EGF-like, type 2, 450001584$IPR001791:Laminin G, 450001815$IPR002049:EGF-like, laminin, 450001927$IPR002172:Low density lipoprotein-receptor, class A, cysteine-rich, 450003159$IPR003598:Immunoglobulin subtype 2, 450005635$IPR006209:EGF, 450005636$IPR006210:EGF-like, 450006486$IPR007110:Immunoglobulin-like, 450011358$IPR012679:Laminin G, subdomain 1, 450011359$IPR012680:Laminin G, subdomain 2, 450011699$IPR013032:EGF-like region, conserved site, 450011742$IPR013098:Immunoglobulin I-set, 450011750$IPR013106:Immunoglobulin V-set, 450011788$IPR013151:Immunoglobulin, 450011956$IPR013320:Concanavalin A-like lectin/glucanase, subgroup, 450012396$IPR013783:Immunoglobulin-like fold, 450016336$IPR018031:Laminin B]
heparan sulfate proteoglycan 2,KEGG_PATHWAY[470038854$hsa04512:ECM-receptor interaction]
heparan sulfate proteoglycan 2,OMIM_DISEASE[520001600$Dyssegmental dysplasia, Silverman-Handmaker type, 520004406$Schwartz-Jampel syndrome, type 1]
heparan sulfate proteoglycan 2,SMART[760000154$SM00180:EGF_Lam, 760000155$SM00181:EGF, 760000166$SM00192:LDLa, 760000173$SM00200:SEA, 760000252$SM00281:LamB, 760000253$SM00282:LamG, 760000356$SM00408:IGc2]
heparan sulfate proteoglycan 2,SP_PIR_KEYWORDS[790000081$angiogenesis, 790000171$basement membrane, 790000308$chondroitin sulfate proteoglycan, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000447$disulfide bond, 790000481$egf-like domain, 790000530$extracellular matrix, 790000616$glycoprotein, 790000667$heparan sulfate, 790000768$Immunoglobulin domain, 790000838$laminin egf-like domain, 790001212$polymorphism, 790001269$proteoglycan, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001556$transmembrane protein]
heparan sulfate proteoglycan 2,UP_SEQ_FEATURE[850007330$chain:Basement membrane-specific heparan sulfate proteoglycan core protein, 850017399$chain:Endorepellin, 850028535$chain:LG3 peptide, 850102883$disulfide bond, 850103597$domain:EGF-like 1, 850103623$domain:EGF-like 2, 850103646$domain:EGF-like 3, 850103668$domain:EGF-like 4, 850104356$domain:Ig-like C2-type 1, 850104357$domain:Ig-like C2-type 10, 850104358$domain:Ig-like C2-type 11, 850104359$domain:Ig-like C2-type 12, 850104360$domain:Ig-like C2-type 13, 850104361$domain:Ig-like C2-type 14, 850104362$domain:Ig-like C2-type 15, 850104363$domain:Ig-like C2-type 16, 850104364$domain:Ig-like C2-type 17, 850104365$domain:Ig-like C2-type 18, 850104366$domain:Ig-like C2-type 19, 850104367$domain:Ig-like C2-type 2, 850104368$domain:Ig-like C2-type 20, 850104369$domain:Ig-like C2-type 21, 850104370$domain:Ig-like C2-type 22, 850104378$domain:Ig-like C2-type 3, 850104389$domain:Ig-like C2-type 4, 850104400$domain:Ig-like C2-type 5, 850104402$domain:Ig-like C2-type 6, 850104403$domain:Ig-like C2-type 7, 850104404$domain:Ig-like C2-type 8, 850104405$domain:Ig-like C2-type 9, 850104602$domain:Laminin EGF-like 10, 850104603$domain:Laminin EGF-like 11, 850104620$domain:Laminin EGF-like 1; first part, 850104621$domain:Laminin EGF-like 1; second part, 850104623$domain:Laminin EGF-like 2, 850104629$domain:Laminin EGF-like 3, 850104634$domain:Laminin EGF-like 4; truncated, 850104636$domain:Laminin EGF-like 5; first part, 850104637$domain:Laminin EGF-like 5; second part, 850104639$domain:Laminin EGF-like 6, 850104641$domain:Laminin EGF-like 7, 850104642$domain:Laminin EGF-like 8, 850104646$domain:Laminin EGF-like 9; first part, 850104647$domain:Laminin EGF-like 9; second part, 850104649$domain:Laminin G-like 1, 850104650$domain:Laminin G-like 2, 850104651$domain:Laminin G-like 3, 850104656$domain:Laminin IV type A 1, 850104657$domain:Laminin IV type A 2, 850104658$domain:Laminin IV type A 3, 850104665$domain:LDL-receptor class A 1, 850104678$domain:LDL-receptor class A 2, 850104691$domain:LDL-receptor class A 3, 850104700$domain:LDL-receptor class A 4, 850105275$domain:SEA, 850105770$glycosylation site:N-linked (GlcNAc...), 850105842$glycosylation site:O-linked (Xyl...) (chondroitin sulfate), 850105847$glycosylation site:O-linked (Xyl...) (heparan sulfate), 850106259$mutagenesis site, 850113401$region of interest:Mediates motor neuron attachment, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118011$site:Cleavage; by BMP1]
hydroxysteroid (17-beta) dehydrogenase 4,BIOCARTA[30000235$h_pparaPathway:Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha)]
hydroxysteroid (17-beta) dehydrogenase 4,INTERPRO[450001950$IPR002198:Short-chain dehydrogenase/reductase SDR, 450002088$IPR002347:Glucose/ribitol dehydrogenase, 450002256$IPR002539:MaoC-like dehydratase, 450002664$IPR003033:Sterol-binding, 450014426$IPR016040:NAD(P)-binding domain]
hydroxysteroid (17-beta) dehydrogenase 4,KEGG_PATHWAY[470038737$hsa00120:Primary bile acid biosynthesis]
hydroxysteroid (17-beta) dehydrogenase 4,OMIM_DISEASE[520001309$D-bifunctional protein deficiency]
hydroxysteroid (17-beta) dehydrogenase 4,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000446$disease mutation, 790000543$fatty acid metabolism, 790000810$Isomerase, 790000873$lipid metabolism, 790000891$lyase, 790001006$nad, 790001092$oxidoreductase, 790001128$peroxisome, 790001162$phosphoprotein, 790001212$polymorphism]
hydroxysteroid (17-beta) dehydrogenase 4,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000454$binding site:NAD, 850000458$binding site:NAD; via amide nitrogen, 850000460$binding site:NAD; via carbonyl oxygen, 850000555$binding site:Substrate, 850037979$chain:Peroxisomal multifunctional enzyme type 2, 850105274$domain:SCP2, 850105852$helix, 850106258$modified residue, 850106301$nucleotide phosphate-binding region:NAD, 850110296$region of interest:3-alpha,7-alpha,12-alpha-trihydroxy-5- beta-cholest-24-enoyl-CoA hydratase, 850110302$region of interest:3-hydroxyacyl-CoA dehydrogenase, 850117295$sequence variant, 850118575$strand, 850118624$turn]
interferon, alpha-inducible protein 27-like 2,INTERPRO[450008421$IPR009311:Interferon-induced 6-16]
interferon, alpha-inducible protein 27-like 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001405$signal, 790001555$transmembrane]
interferon, alpha-inducible protein 27-like 2,UP_SEQ_FEATURE[850026392$chain:Interferon alpha-inducible protein 27- like protein 2, 850117814$signal peptide, 850118623$transmembrane region]
interleukin 1 family, member 6 (epsilon),INTERPRO[450000847$IPR000975:Interleukin-1, 450002873$IPR003294:Interleukin-1, alpha/beta, 450002875$IPR003296:Interleukin-1, beta IL1B]
interleukin 1 family, member 6 (epsilon),SMART[760000107$SM00125:IL1]
interleukin 1 family, member 6 (epsilon),SP_PIR_KEYWORDS[790000356$complete proteome, 790000402$cytokine, 790001038$nitration, 790001212$polymorphism, 790001363$Secreted]
interleukin 1 family, member 6 (epsilon),UP_SEQ_FEATURE[850026493$chain:Interleukin-1 family member 6, 850106258$modified residue, 850117295$sequence variant]
interleukin 19,INTERPRO[450000082$IPR000098:Interleukin-10, 450011046$IPR012351:Four-helical cytokine, core]
interleukin 19,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038866$hsa04630:Jak-STAT signaling pathway]
interleukin 19,PIR_SUPERFAMILY[630003586$PIRSF003542:class 2 cytokine, IL-10 type]
interleukin 19,SMART[760000162$SM00188:IL10]
interleukin 19,SP_PIR_KEYWORDS[790000002$3d-structure, 790000109$Apoptosis, 790000356$complete proteome, 790000402$cytokine, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
interleukin 19,UP_SEQ_FEATURE[850026549$chain:Interleukin-19, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850117295$sequence variant, 850117814$signal peptide, 850118575$strand, 850118624$turn]
intraflagellar transport 81 homolog (Chlamydomonas),SP_PIR_KEYWORDS[790000012$acetylation, 790000050$alternative initiation, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790001162$phosphoprotein, 790001426$spermatogenesis]
intraflagellar transport 81 homolog (Chlamydomonas),UP_SEQ_FEATURE[850026670$chain:Intraflagellar transport protein 81 homolog, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
killer cell lectin-like receptor subfamily C, member 2,INTERPRO[450001149$IPR001304:C-type lectin, 450014523$IPR016186:C-type lectin-like, 450016659$IPR018378:C-type lectin, conserved site]
killer cell lectin-like receptor subfamily C, member 2,KEGG_PATHWAY[470038860$hsa04612:Antigen processing and presentation, 470038868$hsa04650:Natural killer cell mediated cytotoxicity]
killer cell lectin-like receptor subfamily C, member 2,PIR_SUPERFAMILY[630005482$PIRSF005558:natural killer cell receptor CD94/NKG2]
killer cell lectin-like receptor subfamily C, member 2,SMART[760000026$SM00034:CLECT]
killer cell lectin-like receptor subfamily C, member 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000848$Lectin, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001409$Signal-anchor, 790001555$transmembrane, 790001556$transmembrane protein]
killer cell lectin-like receptor subfamily C, member 2,UP_SEQ_FEATURE[850034455$chain:NKG2-C type II integral membrane protein, 850102883$disulfide bond, 850103184$domain:C-type lectin, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
lactate dehydrogenase C,INTERPRO[450001087$IPR001236:Lactate/malate dehydrogenase, 450001383$IPR001557:L-lactate/malate dehydrogenase, 450010206$IPR011304:L-lactate dehydrogenase, 450014366$IPR015955:Lactate dehydrogenase/glycoside hydrolase, family 4, C-terminal, 450016467$IPR018177:L-lactate dehydrogenase, active site]
lactate dehydrogenase C,KEGG_PATHWAY[470038725$hsa00010:Glycolysis / Gluconeogenesis, 470038747$hsa00270:Cysteine and methionine metabolism, 470038787$hsa00620:Pyruvate metabolism, 470038789$hsa00640:Propanoate metabolism]
lactate dehydrogenase C,PIR_SUPERFAMILY[630000119$PIRSF000102:Lac_mal_DH]
lactate dehydrogenase C,SP_PIR_KEYWORDS[790000011$acetylated amino end, 790000356$complete proteome, 790000407$cytoplasm, 790000615$glycolysis, 790000706$homotetramer, 790001006$nad, 790001092$oxidoreductase, 790001212$polymorphism]
lactate dehydrogenase C,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000454$binding site:NAD, 850000457$binding site:NAD or substrate, 850000555$binding site:Substrate, 850027762$chain:L-lactate dehydrogenase C chain, 850106301$nucleotide phosphate-binding region:NAD, 850117294$sequence conflict, 850117295$sequence variant]
mechanistic target of rapamycin (serine/threonine kinase),BBID[10000007$104.Insulin_signaling, 10000008$105.Signaling_glucose_uptake, 10000009$106.Glycogen_synthase-synthesis, 10000010$107.mRNA_translation-protein_synthesis, 10000011$108.Regulating_glucose_transport]
mechanistic target of rapamycin (serine/threonine kinase),BIOCARTA[30000036$h_bcellsurvivalPathway:B Cell Survival Pathway, 30000074$h_ctcfPathway:CTCF: First Multivalent Nuclear Factor, 30000095$h_eif4Pathway:Regulation of eIF4e and p70 S6 Kinase, 30000146$h_igf1mtorpathway:Skeletal muscle hypertrophy is regulated via AKT/mTOR pathway, 30000195$h_mTORPathway:mTOR Signaling Pathway, 30000278$h_stat3Pathway:Stat3 Signaling Pathway]
mechanistic target of rapamycin (serine/threonine kinase),INTERPRO[450000346$IPR000403:Phosphatidylinositol 3- and 4-kinase, catalytic, 450002772$IPR003151:PIK-related kinase, FAT, 450002773$IPR003152:PIK-related kinase, FATC, 450008209$IPR009076:FKBP12-rapamycin-associated protein, FKBP12-rapamycin-binding, 450010814$IPR011989:Armadillo-like helical, 450012603$IPR014009:PIK-related kinase, 450017208$IPR018936:Phosphatidylinositol 3- and 4-kinase, conserved site]
mechanistic target of rapamycin (serine/threonine kinase),KEGG_PATHWAY[470038828$hsa04012:ErbB signaling pathway, 470038842$hsa04150:mTOR signaling pathway, 470038882$hsa04910:Insulin signaling pathway, 470038886$hsa04920:Adipocytokine signaling pathway, 470038887$hsa04930:Type II diabetes mellitus, 470038899$hsa05200:Pathways in cancer, 470038904$hsa05214:Glioma, 470038905$hsa05215:Prostate cancer, 470038911$hsa05221:Acute myeloid leukemia]
mechanistic target of rapamycin (serine/threonine kinase),PIR_SUPERFAMILY[630000831$PIRSF000721:yeast TOR2 protein]
mechanistic target of rapamycin (serine/threonine kinase),SMART[760000128$SM00146:PI3Kc]
mechanistic target of rapamycin (serine/threonine kinase),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000138$atp-binding, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000624$golgi apparatus, 790000825$kinase, 790000919$membrane, 790000969$mitochondrion, 790000971$mitochondrion outer membrane, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001547$transferase]
mechanistic target of rapamycin (serine/threonine kinase),UP_SEQ_FEATURE[850059861$chain:Serine/threonine-protein kinase mTOR, 850103751$domain:FAT, 850103752$domain:FATC, 850104992$domain:PI3K/PI4K, 850105852$helix, 850106258$modified residue, 850116140$repeat:HEAT 1, 850116152$repeat:HEAT 2, 850116162$repeat:HEAT 3, 850116163$repeat:HEAT 4, 850116164$repeat:HEAT 5, 850116165$repeat:HEAT 6, 850116166$repeat:HEAT 7, 850117294$sequence conflict, 850117295$sequence variant]
membrane-associated ring finger (C3HC4) 5,COG_ONTOLOGY[90000102$RNA processing and modification]
membrane-associated ring finger (C3HC4) 5,INTERPRO[450010001$IPR011016:Zinc finger, RING-CH-type, 450017227$IPR018957:Zinc finger, C3HC4 RING-type]
membrane-associated ring finger (C3HC4) 5,SMART[760000650$SM00744:RINGv]
membrane-associated ring finger (C3HC4) 5,SP_PIR_KEYWORDS[790000356$complete proteome, 790000859$ligase, 790000919$membrane, 790000937$metal-binding, 790000969$mitochondrion, 790000971$mitochondrion outer membrane, 790001555$transmembrane, 790001593$ubl conjugation pathway, 790001648$zinc, 790001651$zinc-finger]
membrane-associated ring finger (C3HC4) 5,UP_SEQ_FEATURE[850016670$chain:E3 ubiquitin-protein ligase MARCH5, 850118623$transmembrane region, 850118910$zinc finger region:RING-CH-type]
mesogenin 1,INTERPRO[450000957$IPR001092:Basic helix-loop-helix dimerisation region bHLH]
mesogenin 1,SMART[760000321$SM00353:HLH]
mesogenin 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790000466$dna-binding, 790001065$nucleus, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
mesogenin 1,UP_SEQ_FEATURE[850031219$chain:Mesogenin-1, 850102900$DNA-binding region:Basic motif, 850104114$domain:Helix-loop-helix motif, 850117295$sequence variant]
mitochondrial ribosomal protein L55,INTERPRO[450016887$IPR018615:Ribosomal protein L55, mitochondrial]
mitochondrial ribosomal protein L55,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000969$mitochondrion, 790001212$polymorphism, 790001325$ribonucleoprotein, 790001329$ribosomal protein, 790001550$transit peptide]
mitochondrial ribosomal protein L55,UP_SEQ_FEATURE[850001800$chain:39S ribosomal protein L55, mitochondrial, 850117295$sequence variant, 850118574$splice variant, 850118617$transit peptide:Mitochondrion]
mitochondrial ribosome recycling factor,INTERPRO[450002361$IPR002661:Ribosome recycling factor, 450014401$IPR016000:Ribosome recycling factor, metazoan]
mitochondrial ribosome recycling factor,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000969$mitochondrion, 790001212$polymorphism, 790001255$protein biosynthesis, 790001550$transit peptide]
mitochondrial ribosome recycling factor,UP_SEQ_FEATURE[850058068$chain:Ribosome-recycling factor, mitochondrial, 850117295$sequence variant, 850118574$splice variant, 850118617$transit peptide:Mitochondrion]
mucin-like 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000445$direct protein sequencing, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001304$repeat, 790001363$Secreted, 790001405$signal]
mucin-like 1,UP_SEQ_FEATURE[850032665$chain:Mucin-like protein 1, 850102605$compositionally biased region:Thr-rich, 850105822$glycosylation site:O-linked (GalNAc...), 850110271$region of interest:3 X 8 AA tandem repeat of T-T-A-A-[APS]- T-T-A, 850115074$repeat:1, 850115273$repeat:2, 850115417$repeat:3, 850117295$sequence variant, 850117814$signal peptide]
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10,INTERPRO[450001740$IPR001965:Zinc finger, PHD-type, 450018019$IPR019786:Zinc finger, PHD-type, conserved site, 450018020$IPR019787:Zinc finger, PHD-finger]
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10,OMIM_DISEASE[520002837$Leukemia, acute myeloid, 520002853$Leukemia, acute T-cell lymphoblastic]
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10,SMART[760000221$SM00249:PHD]
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10,SP_PIR_KEYWORDS[790000316$chromosomal rearrangement, 790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001271$Proto-oncogene, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10,UP_SEQ_FEATURE[850045001$chain:Protein AF-10, 850102511$compositionally biased region:Glu/Lys-rich, 850102581$compositionally biased region:Poly-Ser, 850104712$domain:Leucine-zipper, 850106258$modified residue, 850111458$region of interest:DNA-binding, 850112338$region of interest:Interaction with FSTL3, 850114622$region of interest:Self-association, 850114898$region of interest:Transactivation domain, 850118433$site:MLL fusion point (in acute myeloid leukemia patient A), 850118434$site:MLL fusion point (in acute myeloid leukemia patient B), 850118435$site:MLL fusion point (in acute myeloid leukemia patient C), 850118762$zinc finger region:C4-type, 850118878$zinc finger region:PHD-type 1, 850118880$zinc finger region:PHD-type 2]
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 11,OMIM_DISEASE[520002843$Leukemia, acute myelomonocytic]
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 11,SP_PIR_KEYWORDS[790000316$chromosomal rearrangement, 790000356$complete proteome, 790001271$Proto-oncogene]
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 11,UP_SEQ_FEATURE[850045005$chain:Protein AF1q]
neural precursor cell expressed, developmentally down-regulated 8; similar to neural precursor cell expressed, developmentally down-regulated gene 8,BIOCARTA[30000213$h_p27Pathway:Regulation of p27 Phosphorylation during Cell Cycle Progression]
neural precursor cell expressed, developmentally down-regulated 8; similar to neural precursor cell expressed, developmentally down-regulated gene 8,INTERPRO[450000534$IPR000626:Ubiquitin, 450018184$IPR019954:Ubiquitin conserved site, 450018185$IPR019955:Ubiquitin supergroup, 450018186$IPR019956:Ubiquitin subgroup]
neural precursor cell expressed, developmentally down-regulated 8; similar to neural precursor cell expressed, developmentally down-regulated gene 8,PIR_SUPERFAMILY[630002173$PIRSF002034:ubiquitin]
neural precursor cell expressed, developmentally down-regulated 8; similar to neural precursor cell expressed, developmentally down-regulated gene 8,SMART[760000186$SM00213:UBQ]
neural precursor cell expressed, developmentally down-regulated 8; similar to neural precursor cell expressed, developmentally down-regulated gene 8,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000445$direct protein sequencing, 790000811$isopeptide bond, 790001065$nucleus, 790001593$ubl conjugation pathway]
neural precursor cell expressed, developmentally down-regulated 8; similar to neural precursor cell expressed, developmentally down-regulated gene 8,UP_SEQ_FEATURE[850033803$chain:NEDD8, 850102710$cross-link:Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins), 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850112991$region of interest:Interaction with UBE1C, 850117294$sequence conflict, 850118345$site:Interaction with UBE1C, 850118575$strand]
neuropeptide FF-amide peptide precursor,INTERPRO[450007402$IPR008065:FMRFamide-related peptide 2, 450015708$IPR017382:FMRFamide-related peptide 2, subgroup]
neuropeptide FF-amide peptide precursor,PIR_SUPERFAMILY[630029674$PIRSF038092:FMRFamid-rel_pep_precur, 630029675$PIRSF038092:FMRFamide-related peptides precursor]
neuropeptide FF-amide peptide precursor,SP_PIR_KEYWORDS[790000060$amidation, 790000329$cleavage on pair of basic residues, 790000356$complete proteome, 790001021$neuropeptide, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
neuropeptide FF-amide peptide precursor,UP_SEQ_FEATURE[850106258$modified residue, 850108384$peptide:Neuropeptide AF, 850108392$peptide:Neuropeptide FF, 850108408$peptide:Neuropeptide SF, 850117295$sequence variant, 850117814$signal peptide]
nuclear receptor co-repressor 2,BIOCARTA[30000046$h_carm-erPathway:CARM1 and Regulation of the Estrogen Receptor, 30000092$h_egfr_smrtePathway:Map Kinase Inactivation of SMRT Corepressor, 30000108$h_etsPathway:METS affect on Macrophage Differentiation, 30000235$h_pparaPathway:Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha), 30000254$h_rarrxrPathway:Nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription in carcinoma cells]
nuclear receptor co-repressor 2,INTERPRO[450000876$IPR001005:SANT, DNA-binding, 450010997$IPR012287:Homeodomain-related, 450013228$IPR014778:Myb, DNA-binding, 450016201$IPR017884:SANT, eukarya]
nuclear receptor co-repressor 2,KEGG_PATHWAY[470038848$hsa04330:Notch signaling pathway]
nuclear receptor co-repressor 2,SMART[760000623$SM00717:SANT]
nuclear receptor co-repressor 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
nuclear receptor co-repressor 2,UP_SEQ_FEATURE[850035037$chain:Nuclear receptor corepressor 2, 850102570$compositionally biased region:Poly-Gln, 850102573$compositionally biased region:Poly-Gly, 850102577$compositionally biased region:Poly-Lys, 850102580$compositionally biased region:Poly-Pro, 850102586$compositionally biased region:Pro-rich, 850105255$domain:SANT 1, 850105256$domain:SANT 2, 850105852$helix, 850106258$modified residue, 850112828$region of interest:Interaction with SIN3A/B, 850117294$sequence conflict, 850117295$sequence variant, 850117349$short sequence motif:CORNR box of ID1, 850117350$short sequence motif:CORNR box of ID2, 850118574$splice variant, 850118575$strand, 850118624$turn]
nuclear transcription factor Y, gamma,BIOCARTA[30000290$h_tercPathway:Overview of telomerase RNA component gene hTerc Transcriptional Regulation]
nuclear transcription factor Y, gamma,COG_ONTOLOGY[90000115$Transcription]
nuclear transcription factor Y, gamma,INTERPRO[450003481$IPR003958:Transcription factor CBF/NF-Y/archaeal histone, 450008207$IPR009072:Histone-fold]
nuclear transcription factor Y, gamma,KEGG_PATHWAY[470038860$hsa04612:Antigen processing and presentation]
nuclear transcription factor Y, gamma,SP_PIR_KEYWORDS[790000002$3d-structure, 790000020$activator, 790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
nuclear transcription factor Y, gamma,UP_SEQ_FEATURE[850035111$chain:Nuclear transcription factor Y subunit gamma, 850105852$helix, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
nudix (nucleoside diphosphate linked moiety X)-type motif 8,INTERPRO[450000072$IPR000086:NUDIX hydrolase domain, 450000073$IPR000086:NUDIX hydrolase, core]
nudix (nucleoside diphosphate linked moiety X)-type motif 8,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000743$hydrolase, 790000899$magnesium, 790000906$manganese, 790000937$metal-binding, 790000969$mitochondrion, 790001550$transit peptide]
nudix (nucleoside diphosphate linked moiety X)-type motif 8,UP_SEQ_FEATURE[850035300$chain:Nucleoside diphosphate-linked moiety X motif 8, mitochondrial, 850104864$domain:Nudix hydrolase, 850106148$metal ion-binding site:Magnesium or manganese, 850117628$short sequence motif:Nudix box, 850118574$splice variant, 850118617$transit peptide:Mitochondrion]
olfactory receptor, family 2, subfamily M, member 7,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450000624$IPR000725:Olfactory receptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
olfactory receptor, family 2, subfamily M, member 7,KEGG_PATHWAY[470038879$hsa04740:Olfactory transduction]
olfactory receptor, family 2, subfamily M, member 7,PIR_SUPERFAMILY[630003245$PIRSF003152:G protein-coupled olfactory receptor, class II, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
olfactory receptor, family 2, subfamily M, member 7,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001069$olfaction, 790001212$polymorphism, 790001301$receptor, 790001377$sensory transduction, 790001546$transducer, 790001555$transmembrane]
olfactory receptor, family 2, subfamily M, member 7,UP_SEQ_FEATURE[850035692$chain:Olfactory receptor 2M7, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
olfactory receptor, family 2, subfamily T, member 6,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450000624$IPR000725:Olfactory receptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
olfactory receptor, family 2, subfamily T, member 6,KEGG_PATHWAY[470038879$hsa04740:Olfactory transduction]
olfactory receptor, family 2, subfamily T, member 6,PIR_SUPERFAMILY[630003245$PIRSF003152:G protein-coupled olfactory receptor, class II, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
olfactory receptor, family 2, subfamily T, member 6,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001069$olfaction, 790001212$polymorphism, 790001301$receptor, 790001377$sensory transduction, 790001546$transducer, 790001555$transmembrane]
olfactory receptor, family 2, subfamily T, member 6,UP_SEQ_FEATURE[850035707$chain:Olfactory receptor 2T6, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
organic solute transporter beta,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000919$membrane, 790001555$transmembrane, 790001558$transport]
organic solute transporter beta,UP_SEQ_FEATURE[850036195$chain:Organic solute transporter subunit beta, 850117294$sequence conflict, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
osteosarcoma amplified 9, endoplasmic reticulum associated protein,INTERPRO[450011589$IPR012913:Glucosidase II beta subunit-like]
osteosarcoma amplified 9, endoplasmic reticulum associated protein,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000243$carcinogenesis, 790000356$complete proteome, 790000447$disulfide bond, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790000848$Lectin, 790001212$polymorphism, 790001405$signal]
osteosarcoma amplified 9, endoplasmic reticulum associated protein,UP_SEQ_FEATURE[850047109$chain:Protein OS-9, 850102464$compositionally biased region:Asp/Glu-rich (acidic), 850105082$domain:PRKCSH, 850105770$glycosylation site:N-linked (GlcNAc...), 850106259$mutagenesis site, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
placenta-specific 1-like,SP_PIR_KEYWORDS[790000356$complete proteome, 790001363$Secreted, 790001405$signal]
placenta-specific 1-like,UP_SEQ_FEATURE[850039406$chain:Placenta-specific 1-like protein, 850117294$sequence conflict, 850117814$signal peptide]
polyhomeotic homolog 2 (Drosophila),INTERPRO[450001470$IPR001660:Sterile alpha motif SAM, 450011016$IPR012313:Zinc finger, FCS-type, 450012380$IPR013761:Sterile alpha motif-type]
polyhomeotic homolog 2 (Drosophila),SMART[760000399$SM00454:SAM]
polyhomeotic homolog 2 (Drosophila),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000428$developmental protein, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001648$zinc, 790001651$zinc-finger]
polyhomeotic homolog 2 (Drosophila),UP_SEQ_FEATURE[850039880$chain:Polyhomeotic-like protein 2, 850102485$compositionally biased region:Gln-rich, 850102597$compositionally biased region:Ser-rich, 850105249$domain:SAM, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117481$short sequence motif:HD1, 850118574$splice variant, 850118807$zinc finger region:FCS-type]
protamine 1,INTERPRO[450000190$IPR000221:Protamine P1]
protamine 1,PIR_SUPERFAMILY[630002198$PIRSF002067:sperm histone]
protamine 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000315$chromosomal protein, 790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000449$DNA binding, 790000451$dna condensation, 790000466$dna-binding, 790001058$nucleosome core, 790001065$nucleus, 790001162$phosphoprotein, 790001426$spermatogenesis]
protamine 1,UP_SEQ_FEATURE[850061810$chain:Sperm protamine-P1, 850102883$disulfide bond]
protein tyrosine phosphatase, non-receptor type 6,BIOCARTA[30000100$h_epoPathway:EPO Signaling Pathway, 30000125$h_ghPathway:Growth Hormone Signaling Pathway, 30000156$h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation, 30000157$h_il3Pathway:IL 3 signaling pathway, 30000202$h_nkcellsPathway:Ras-Independent pathway in NK cell-mediated cytotoxicity]
protein tyrosine phosphatase, non-receptor type 6,INTERPRO[450000210$IPR000242:Protein-tyrosine phosphatase, receptor/non-receptor type, 450000330$IPR000387:Dual-specific/protein-tyrosine phosphatase, conserved region, 450000331$IPR000387:Protein-tyrosine phosphatase, 450000852$IPR000980:SH2 motif, 450010930$IPR012152:Protein-tyrosine phosphatase, non-receptor type-6, -11, 450014489$IPR016130:Protein-tyrosine phosphatase, active site]
protein tyrosine phosphatase, non-receptor type 6,KEGG_PATHWAY[470038856$hsa04520:Adherens junction, 470038866$hsa04630:Jak-STAT signaling pathway, 470038868$hsa04650:Natural killer cell mediated cytotoxicity, 470038869$hsa04660:T cell receptor signaling pathway, 470038870$hsa04662:B cell receptor signaling pathway]
protein tyrosine phosphatase, non-receptor type 6,PIR_SUPERFAMILY[630001073$PIRSF000929:non-receptor tyrosine-protein phosphatase, 6/11 types, 630001074$PIRSF000929:Tyr-Ptase_nr_6]
protein tyrosine phosphatase, non-receptor type 6,SMART[760000168$SM00194:PTPc, 760000224$SM00252:SH2]
protein tyrosine phosphatase, non-receptor type 6,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase, 790001065$nucleus, 790001162$phosphoprotein, 790001164$phosphoric monoester hydrolase, 790001261$protein phosphatase, 790001301$receptor, 790001304$repeat, 790001397$SH2 domain, 790001587$tyrosine-specific phosphatase]
protein tyrosine phosphatase, non-receptor type 6,UP_SEQ_FEATURE[850000106$active site:Phosphocysteine intermediate, 850067660$chain:Tyrosine-protein phosphatase non-receptor type 6, 850105347$domain:SH2 1, 850105348$domain:SH2 2, 850105593$domain:Tyrosine-protein phosphatase, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118624$turn]
regulating synaptic membrane exocytosis 3,INTERPRO[450000006$IPR000008:C2 calcium-dependent membrane targeting, 450016334$IPR018029:C2 membrane targeting protein]
regulating synaptic membrane exocytosis 3,SMART[760000211$SM00239:C2]
regulating synaptic membrane exocytosis 3,SP_PIR_KEYWORDS[790000263$cell junction, 790000356$complete proteome, 790000522$exocytosis, 790001027$neurotransmitter transport, 790001162$phosphoprotein, 790001475$synapse, 790001558$transport]
regulating synaptic membrane exocytosis 3,UP_SEQ_FEATURE[850057006$chain:Regulating synaptic membrane exocytosis protein 3, 850103199$domain:C2, 850106258$modified residue, 850117294$sequence conflict]
relaxin 3,BIOCARTA[30000046$h_carm-erPathway:CARM1 and Regulation of the Estrogen Receptor]
relaxin 3,INTERPRO[450004307$IPR004825:Insulin/IGF/relaxin]
relaxin 3,PIR_SUPERFAMILY[630028565$PIRSF037063:relaxin-3/insulin-like peptide 5, 630030554$PIRSF500316:relaxin 3]
relaxin 3,SMART[760000068$SM00078:IlGF]
relaxin 3,SP_PIR_KEYWORDS[790000002$3d-structure, 790000329$cleavage on pair of basic residues, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000708$hormone, 790001363$Secreted, 790001405$signal]
relaxin 3,UP_SEQ_FEATURE[850102883$disulfide bond, 850105852$helix, 850109027$peptide:Relaxin-3 A chain, 850109028$peptide:Relaxin-3 B chain, 850109655$propeptide:Connecting peptide, 850117814$signal peptide, 850118575$strand]
repetin,INTERPRO[450001551$IPR001751:S100/CaBP-9k-type, calcium binding, 450010817$IPR011992:EF-Hand type, 450012399$IPR013787:S100/CaBP-9k-type, calcium binding, subdomain, 450016532$IPR018247:EF-HAND 1, 450016533$IPR018248:EF hand, 450016534$IPR018249:EF-HAND 2]
repetin,SP_PIR_KEYWORDS[790000211$calcium, 790000356$complete proteome, 790000530$extracellular matrix, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001363$Secreted]
repetin,UP_SEQ_FEATURE[850000620$calcium-binding region:1; low affinity, 850000624$calcium-binding region:2; high affinity, 850057176$chain:Repetin, 850102485$compositionally biased region:Gln-rich, 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850106258$modified residue, 850114567$region of interest:S-100-like, 850117295$sequence variant]
ribosomal protein L12 pseudogene 2; ribosomal protein L12 pseudogene 32; ribosomal protein L12 pseudogene 35; ribosomal protein L12 pseudogene 19; ribosomal protein L12 pseudogene 6; ribosomal protein L12; ribosomal protein L12 pseudogene 14,INTERPRO[450000794$IPR000911:Ribosomal protein L11]
ribosomal protein L12 pseudogene 2; ribosomal protein L12 pseudogene 32; ribosomal protein L12 pseudogene 35; ribosomal protein L12 pseudogene 19; ribosomal protein L12 pseudogene 6; ribosomal protein L12; ribosomal protein L12 pseudogene 14,KEGG_PATHWAY[470038813$hsa03010:Ribosome]
ribosomal protein L12 pseudogene 2; ribosomal protein L12 pseudogene 32; ribosomal protein L12 pseudogene 35; ribosomal protein L12 pseudogene 19; ribosomal protein L12 pseudogene 6; ribosomal protein L12; ribosomal protein L12 pseudogene 14,PIR_SUPERFAMILY[630002311$PIRSF002179:ribosomal protein, L11p/L11a/L12e/organellar L11 types, 630030345$PIRSF500071:ribosomal protein L12e]
ribosomal protein L12 pseudogene 2; ribosomal protein L12 pseudogene 32; ribosomal protein L12 pseudogene 35; ribosomal protein L12 pseudogene 19; ribosomal protein L12 pseudogene 6; ribosomal protein L12; ribosomal protein L12 pseudogene 14,SMART[760000564$SM00649:RL11]
ribosomal protein L12 pseudogene 2; ribosomal protein L12 pseudogene 32; ribosomal protein L12 pseudogene 35; ribosomal protein L12 pseudogene 19; ribosomal protein L12 pseudogene 6; ribosomal protein L12; ribosomal protein L12 pseudogene 14,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001255$protein biosynthesis, 790001325$ribonucleoprotein, 790001329$ribosomal protein, 790001330$ribosome, 790001339$rna-binding]
ribosomal protein L12 pseudogene 2; ribosomal protein L12 pseudogene 32; ribosomal protein L12 pseudogene 35; ribosomal protein L12 pseudogene 19; ribosomal protein L12 pseudogene 6; ribosomal protein L12; ribosomal protein L12 pseudogene 14,UP_SEQ_FEATURE[850002604$chain:60S ribosomal protein L12, 850106258$modified residue, 850118574$splice variant]
ribosomal protein L35; ribosomal protein L35 pseudogene 1; ribosomal protein L35 pseudogene 2,INTERPRO[450001640$IPR001854:Ribosomal protein L29, 450016539$IPR018254:Ribosomal protein L29, conserved site]
ribosomal protein L35; ribosomal protein L35 pseudogene 1; ribosomal protein L35 pseudogene 2,KEGG_PATHWAY[470038813$hsa03010:Ribosome]
ribosomal protein L35; ribosomal protein L35 pseudogene 1; ribosomal protein L35 pseudogene 2,PIR_SUPERFAMILY[630002367$PIRSF002235:ribosomal protein L35]
ribosomal protein L35; ribosomal protein L35 pseudogene 1; ribosomal protein L35 pseudogene 2,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000445$direct protein sequencing, 790001325$ribonucleoprotein, 790001329$ribosomal protein]
ribosomal protein L35; ribosomal protein L35 pseudogene 1; ribosomal protein L35 pseudogene 2,UP_SEQ_FEATURE[850002748$chain:60S ribosomal protein L35, 850106258$modified residue, 850117294$sequence conflict]
ring finger protein 141,INTERPRO[450001628$IPR001841:Zinc finger, RING-type, 450016222$IPR017907:Zinc finger, RING-type, conserved site, 450017227$IPR018957:Zinc finger, C3HC4 RING-type]
ring finger protein 141,PIR_SUPERFAMILY[630018910$PIRSF023448:hypothetical protein F54B11.5]
ring finger protein 141,SMART[760000158$SM00184:RING]
ring finger protein 141,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000937$metal-binding, 790001648$zinc, 790001651$zinc-finger]
ring finger protein 141,UP_SEQ_FEATURE[850058185$chain:RING finger protein 141, 850105852$helix, 850117294$sequence conflict, 850118575$strand, 850118624$turn, 850118911$zinc finger region:RING-type]
sialic acid binding Ig-like lectin 10,INTERPRO[450002642$IPR003006:Immunoglobulin/major histocompatibility complex, conserved site, 450003159$IPR003598:Immunoglobulin subtype 2, 450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011750$IPR013106:Immunoglobulin V-set, 450011788$IPR013151:Immunoglobulin, 450011799$IPR013162:CD80-like, immunoglobulin C2-set]
sialic acid binding Ig-like lectin 10,SMART[760000356$SM00408:IGc2, 760000357$SM00409:IG]
sialic acid binding Ig-like lectin 10,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000256$cell adhesion, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000848$Lectin, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001555$transmembrane]
sialic acid binding Ig-like lectin 10,UP_SEQ_FEATURE[850000550$binding site:Sialic acid, 850060683$chain:Sialic acid-binding Ig-like lectin 10, 850102883$disulfide bond, 850104356$domain:Ig-like C2-type 1, 850104367$domain:Ig-like C2-type 2, 850104378$domain:Ig-like C2-type 3, 850104407$domain:Ig-like V-type, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850117520$short sequence motif:ITIM motif 1, 850117521$short sequence motif:ITIM motif 2, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
solute carrier family 16, member 1 (monocarboxylic acid transporter 1),INTERPRO[450004231$IPR004743:Monocarboxylate transporter, 450010529$IPR011701:Major facilitator superfamily MFS-1]
solute carrier family 16, member 1 (monocarboxylic acid transporter 1),OMIM_DISEASE[520001797$Erythrocyte lactate transporter defect, 520002437$Hyperinsulinemic hypoglycemia, familial, 7]
solute carrier family 16, member 1 (monocarboxylic acid transporter 1),PIR_SUPERFAMILY[630006285$PIRSF006350:monocarbosylate transporter MCT2]
solute carrier family 16, member 1 (monocarboxylic acid transporter 1),SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000446$disease mutation, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001473$Symport, 790001555$transmembrane, 790001558$transport]
solute carrier family 16, member 1 (monocarboxylic acid transporter 1),UP_SEQ_FEATURE[850032407$chain:Monocarboxylate transporter 1, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
solute carrier family 38, member 6,INTERPRO[450011718$IPR013057:Amino acid transporter, transmembrane]
solute carrier family 38, member 6,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000065$amino-acid transport, 790000356$complete proteome, 790000616$glycoprotein, 790000798$ion transport, 790000919$membrane, 790001212$polymorphism, 790001418$Sodium, 790001421$Sodium transport, 790001555$transmembrane, 790001558$transport]
solute carrier family 38, member 6,UP_SEQ_FEATURE[850043844$chain:Probable sodium-coupled neutral amino acid transporter 6, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
solute carrier organic anion transporter family, member 2B1,INTERPRO[450003667$IPR004156:Organic anion transporter polypeptide OATP]
solute carrier organic anion transporter family, member 2B1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000798$ion transport, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane, 790001558$transport]
solute carrier organic anion transporter family, member 2B1,UP_SEQ_FEATURE[850061471$chain:Solute carrier organic anion transporter family member 2B1, 850104500$domain:Kazal-like, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
sterol carrier protein 2,INTERPRO[450001912$IPR002155:Thiolase, 450001950$IPR002198:Short-chain dehydrogenase/reductase SDR, 450002664$IPR003033:Sterol-binding, 450014425$IPR016038:Thiolase-like, subgroup]
sterol carrier protein 2,KEGG_PATHWAY[470038737$hsa00120:Primary bile acid biosynthesis, 470038821$hsa03320:PPAR signaling pathway]
sterol carrier protein 2,OMIM_DISEASE[520002884$Leukoencephalopathy with dystonia and motor neuropathy]
sterol carrier protein 2,PIR_SUPERFAMILY[630000504$PIRSF000429:Ac-CoA_Ac_transf]
sterol carrier protein 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000050$alternative initiation, 790000051$alternative initiators, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000875$lipid transport, 790000876$lipid-binding, 790000969$mitochondrion, 790001128$peroxisome, 790001162$phosphoprotein, 790001212$polymorphism, 790001547$transferase, 790001550$transit peptide, 790001558$transport]
sterol carrier protein 2,UP_SEQ_FEATURE[850034585$chain:Non-specific lipid-transfer protein, 850105274$domain:SCP2, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850117578$short sequence motif:Microbody targeting signal, 850118574$splice variant, 850118575$strand, 850118624$turn]
sulfite oxidase,INTERPRO[450000487$IPR000572:Oxidoreductase, molybdopterin binding, 450001053$IPR001199:Cytochrome b5, 450004535$IPR005066:Moybdenum cofactor oxidoreductase, dimerisation, 450007613$IPR008335:Eukaryotic molybdopterin oxidoreductase, 450016778$IPR018506:Cytochrome b5, heme-binding site]
sulfite oxidase,KEGG_PATHWAY[470038806$hsa00920:Sulfur metabolism]
sulfite oxidase,OMIM_DISEASE[520000075$A novel susceptibility locus for type 1 diabetes on Chr12q13 identified by a genome-wide association study, 520004717$Sulfite oxidase deficiency]
sulfite oxidase,PIR_SUPERFAMILY[630000303$PIRSF000257:sulfite oxidase]
sulfite oxidase,SP_PIR_KEYWORDS[790000002$3d-structure, 790000314$chromoprotein, 790000356$complete proteome, 790000446$disease mutation, 790000652$heme, 790000701$homodimer, 790000802$iron, 790000937$metal-binding, 790000943$metalloprotein, 790000969$mitochondrion, 790000977$Molybdenum, 790000980$molybdopterin, 790001092$oxidoreductase, 790001162$phosphoprotein, 790001550$transit peptide]
sulfite oxidase,UP_SEQ_FEATURE[850062881$chain:Sulfite oxidase, mitochondrial, 850103472$domain:Cytochrome b5 heme-binding, 850105852$helix, 850106026$metal ion-binding site:Iron (heme axial ligand), 850106192$metal ion-binding site:Molybdenum-pterin, 850106258$modified residue, 850111880$region of interest:Hinge, 850113472$region of interest:Molybdenum-pterin domain, 850113473$region of interest:Molybdenum-pterin-binding, 850117295$sequence variant, 850118575$strand, 850118617$transit peptide:Mitochondrion, 850118624$turn]
survival motor neuron domain containing 1,INTERPRO[450002638$IPR002999:Tudor domain, 450009372$IPR010304:Survival motor neuron, 450016636$IPR018351:Tudor subgroup]
survival motor neuron domain containing 1,KEGG_PATHWAY[470038818$hsa03040:Spliceosome]
survival motor neuron domain containing 1,SMART[760000302$SM00333:TUDOR]
survival motor neuron domain containing 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000109$Apoptosis, 790000356$complete proteome, 790000445$direct protein sequencing, 790000988$mrna processing, 790000989$mrna splicing, 790001065$nucleus, 790001162$phosphoprotein, 790001433$Spliceosome]
survival motor neuron domain containing 1,UP_SEQ_FEATURE[850063069$chain:Survival of motor neuron-related-splicing factor 30, 850105583$domain:Tudor, 850106258$modified residue, 850117610$short sequence motif:Nuclear localization signal]
testis expressed 264,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790001162$phosphoprotein, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
testis expressed 264,UP_SEQ_FEATURE[850063890$chain:Testis-expressed sequence 264 protein, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117295$sequence variant, 850117814$signal peptide]
trafficking protein particle complex 3,INTERPRO[450006565$IPR007194:Transport protein particle (TRAPP) component, 450015041$IPR016721:TRAPP I complex, Bet3]
trafficking protein particle complex 3,PIR_SUPERFAMILY[630014916$PIRSF018293:TRAPP I complex, Bet3 subunit, 630014917$PIRSF018293:TRAPP_I_complex_Bet3]
trafficking protein particle complex 3,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000510$er-golgi transport, 790000624$golgi apparatus, 790000881$lipoprotein, 790001100$palmitate, 790001558$transport]
trafficking protein particle complex 3,UP_SEQ_FEATURE[850064883$chain:Trafficking protein particle complex subunit 3, 850105852$helix, 850105898$lipid moiety-binding region:S-palmitoyl cysteine, 850106259$mutagenesis site, 850118575$strand, 850118624$turn]
tumor necrosis factor, alpha-induced protein 2,INTERPRO[450009392$IPR010326:Exocyst complex component Sec6]
tumor necrosis factor, alpha-induced protein 2,SP_PIR_KEYWORDS[790000081$angiogenesis, 790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790001212$polymorphism]
tumor necrosis factor, alpha-induced protein 2,UP_SEQ_FEATURE[850067225$chain:Tumor necrosis factor, alpha-induced protein 2, 850102555$compositionally biased region:Lys-rich (basic), 850102565$compositionally biased region:Poly-Ala, 850102572$compositionally biased region:Poly-Glu, 850117295$sequence variant]
up-regulated during skeletal muscle growth 5 homolog (mouse),INTERPRO[450008245$IPR009125:DAPIT]
up-regulated during skeletal muscle growth 5 homolog (mouse),SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000919$membrane, 790000969$mitochondrion, 790001555$transmembrane]
up-regulated during skeletal muscle growth 5 homolog (mouse),UP_SEQ_FEATURE[850083125$chain:Up-regulated during skeletal muscle growth protein 5, 850106258$modified residue, 850118623$transmembrane region]
urotensin 2,INTERPRO[450001321$IPR001483:Urotensin II]
urotensin 2,PIR_SUPERFAMILY[630001939$PIRSF001793:urotensin II]
urotensin 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000329$cleavage on pair of basic residues, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000708$hormone, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
urotensin 2,UP_SEQ_FEATURE[850102883$disulfide bond, 850109536$peptide:Urotensin-2, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian),BIOCARTA[30000102$h_ErbB3Pathway:Neuroregulin receptor degredation protein-1 Controls ErbB3 receptor recycling, 30000136$h_her2Pathway:Role of ERBB2 in Signal Transduction and Oncology]
v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian),INTERPRO[450000421$IPR000494:EGF receptor, L domain, 450000618$IPR000719:Protein kinase, core, 450001096$IPR001245:Tyrosine protein kinase, 450005637$IPR006211:Furin-like cysteine rich region, 450005638$IPR006212:Furin-like repeat, 450007559$IPR008266:Tyrosine protein kinase, active site, 450014569$IPR016245:Tyrosine protein kinase, receptor-type, EGF/ERB/XmrK, 450015769$IPR017441:Protein kinase, ATP binding site]
v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian),KEGG_PATHWAY[470038828$hsa04012:ErbB signaling pathway, 470038829$hsa04020:Calcium signaling pathway, 470038841$hsa04144:Endocytosis]
v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian),OMIM_DISEASE[520000075$A novel susceptibility locus for type 1 diabetes on Chr12q13 identified by a genome-wide association study, 520002016$Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls, 520002825$Lethal congenital contractural syndrome 2, 520002829$lethal congenital contracture syndrome type 2, 520003249$Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci, 520004355$Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes]
v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian),PIR_SUPERFAMILY[630000729$PIRSF000619:TyrPK_EGF-R]
v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian),SMART[760000192$SM00219:TyrKc, 760000233$SM00261:FU]
v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000134$ATP, 790000138$atp-binding, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000825$kinase, 790000919$membrane, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001168$phosphotransferase, 790001212$polymorphism, 790001301$receptor, 790001363$Secreted, 790001405$signal, 790001547$transferase, 790001555$transmembrane, 790001586$tyrosine-protein kinase]
v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian),UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850056905$chain:Receptor tyrosine-protein kinase erbB-3, 850102883$disulfide bond, 850105086$domain:Protein kinase, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
zinc finger with KRAB and SCAN domains 2,COG_ONTOLOGY[90000073$General function prediction only]
zinc finger with KRAB and SCAN domains 2,INTERPRO[450000876$IPR001005:SANT, DNA-binding, 450001691$IPR001909:Krueppel-associated  box, 450002887$IPR003309:Transcriptional regulator SCAN, 450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger with KRAB and SCAN domains 2,SMART[760000317$SM00349:KRAB, 760000323$SM00355:ZnF_C2H2, 760000377$SM00431:SCAN, 760000623$SM00717:SANT]
zinc finger with KRAB and SCAN domains 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger with KRAB and SCAN domains 2,UP_SEQ_FEATURE[850102080$chain:Zinc finger protein with KRAB and SCAN domains 2, 850104552$domain:KRAB, 850105271$domain:SCAN box, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6]
